Report Company Directory

Astec Industries Inc.

• Astec Announces Quarterly Dividend by GlobeNewsWire
• Astec Industries, Inc. Announces the Company’s Second Quarter 2025 Conference Call on August 6, 2025, at 8:30 A.M. Eastern Time by GlobeNewsWire
• Astec Completes Acquisition of TerraSource Holdings, LLC by GlobeNewsWire
• Astec Reports First Quarter 2025 Results, Enters Into Definitive Agreement to Acquire TerraSource Holdings, LLC by GlobeNewsWire
• Astec Announces Quarterly Dividend by GlobeNewsWire
• Astec Industries, Inc. Announces the Company’s First Quarter 2025 Conference Call on April 29, 2025, at 8:30 A.M. Eastern Time by GlobeNewsWire
• Astec to Participate in Sidoti Small Cap Virtual Conference by GlobeNewsWire
• Astec Reports Record Fourth Quarter, Full Year 2024 Results by GlobeNewsWire
• Astec Announces Quarterly Dividend by GlobeNewsWire
• Astec Industries, Inc. (NASDAQ: ASTE) Announces the Company’s Fourth Quarter and Full Year 2024 Conference Call on February 26, 2025, at 8:30 A.M. Eastern Time by GlobeNewsWire

Astec Lifesciences Ltd.

• Astec Lifesciences Ltd: 1 director by SmartInsider
• Ford Equity International Rating and Forecast Report by Ford Equity Research

ASTECH CO. LTD.

Astellas Pharma Inc.

• EM & APAC Equity Strategy "The set-up into the tariff step-up" Tirumalai by UBS AG
• Quick Note - Astellas Pharma (4503 JP) (Buy) - 26/3 Q1 results: Strong start ahead of guidance by Nomura Research
• 1Q results: core OP well above our forecast; eye on FAA/CLDN18.2 targeted drugs by Mizuho Securities
• First Read: アステラス製薬 "1Q決算: 滑り出し順調" (Neutral) 酒井 by UBS AG
• First Read: Astellas Pharma "Q1 results: off to a good start" (Neutral) Sakai by UBS AG
• 1Q決算:コアOPはみずほ証券想定を大きく上回る、FAA・CLDN18.2標的薬の開発進展に期待 by Mizuho Securities
• Quick Note - アステラス製薬 (4503 JP) (Buy) - 決算速報：会社計画を上回る好スタート by Nomura Research
• Pharmaceuticals and biotech sectors - Overseas companies' earnings releases through 29 July by Nomura Research
• 医薬品・バイオテック業界 - 29日までに発表の海外企業決算について by Nomura Research
• Quick Note - Astellas Pharma (4503 JP) (Buy) - Veozah update: US launch of competitor pushed back by Nomura Research

Astellia S.A.

• Ford Equity International Rating and Forecast Report by Ford Equity Research
• SRI Quantitative KPIs by EthiFinance